Axim Biotechnologies Inc
AXIM · PINKDay Range
52 Week Range
Market Cap
605.79KUSD
About
General Information
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US05463V1008
CUSIP
05463V100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
-0.03
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.02
Wall Street Target Price
-
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Profitability
Revenue TTM
92,898
Gross Profit TTM
91,154
EBITDA
-1,883,836
Profit Margin
0.00%
Return On Assets TTM
-36.27%
Return On Equity TTM
-10019.09%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
76.00%
Diluted Eps TTM
-0.02
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
0
Price Sales TTM
6.521
Price Book MRQ
2.8584
Enterprise Value Revenue
78
Enterprise Value EBITDA
-1
Peers analysis
- CMXHFCSL Limited
169.54
3.19% - BNTXBioNTech SE
115.29
2.70% - VRTXVertex Pharmaceuticals Inc
417.40
1.39% - REGNRegeneron Pharmaceuticals Inc
698.48
1.12% - CSLLYCSL Ltd
86.83
0.51%
- ALNYAlnylam Pharmaceuticals Inc
241.09
0.27% - ARGNFargenx SE
655.00
0.00% - UCBJFUCB SA
194.85
0.00% - ARGXargenx NV ADR
661.14
-0.68% - UCBJYUCB SA ADR
97.63
-0.27%
